skip to main content

ES

Leading the Way in Science

For seven decades, we’ve led the way in funding scientific research to conquer arthritis. 

Featured Trial

The PIKASO Clinical Trial

The Preventing Injured Knees from osteoArthritis: Severity Outcomes (PIKASO) Trial marks one of the first multi-stakeholder collaborative initiatives of the Arthritis Foundation’s Osteoarthritis Clinical Trials Network (OA-CTN), a multi-year, $20 million investment in creating an infrastructure to allow leading research centers to execute randomized clinical trials in osteoarthritis (OA) under a common master protocol.

Learn More
The PIKASO Clinical Trial

What’s Happening in Research

The needs of arthritis patients anchor all our scientific endeavors.

Learn More

Our Impact Since 2018

$12M

for Osteoarthritis at 15 Institutions

$12M

for Juvenile Arthritis

$3M

for Rheumatology Workforce Development at 18 Institutions

20+

Research Projects Supported

Fellowships
Workforce Development

Fellowships

The number of rheumatologists in the U.S. is shrinking as the population of people with rheumatic conditions is growing. Fewer physicians are choosing to specialize in the field, which can be more demanding than other specialties, partly because of the shortage The Arthritis Foundation is working to bridge that gap through its fellowship program with the goal to improve health outcomes for adult and pediatric patients living with arthritis.

Learn More
What We’re Doing

Advancing OA Treatments

Osteoarthritis affects over 30 million Americans and is the most common cause of disability. We aim to find ways to treat this disease and improve patients’ quality of life. 

Learn More
Advancing OA Treatments
Conquering Childhood Arthritis
What We’re Doing

Conquering Childhood Arthritis

We’re mobilizing patients and their families to engage in studies comparing the effectiveness of treatments for juvenile arthritis and funding research for more options. 

Learn More
What We’re Doing

Tackling Rheumatoid Arthritis

We’re convening passionate experts — from government to academia and beyond — to help accelerate research that tackles rheumatoid and other inflammatory types of arthritis.

Learn More
Tackling Rheumatoid Arthritis
Cultivating New Specialists
What We’re Doing

Cultivating New Specialists

The growing shortage of rheumatologists causes barriers to getting adequate care and reduces quality of life. We’re working to close the gap, especially in underserved areas. 

Learn More

Dr. Richard Lartey

Mathematician Who’s Making Arthritis History

Meet Richard Lartey, PhD, who is using his math skills to help validate a new kind of MRI technology that measures the status of cartilage and soft tissues in OA and other joint disorders.

Read His Story

Scientists We’re Funding

Repurposing Drugs for OA?

Reza Jafarzadeh is evaluating if approved drugs may be effective to treat or prevent osteoarthritis.

Learn More

Latest ACR Guidelines for Managing RA

The American College of Rheumatology weighs in on rheumatoid arthritis treatments. What are the main takeaways?
Read More

In Search of Drugs for Osteoarthritis

Learn about our workshop with the FDA to explore the challenges and potential solutions of developing new OA treatments.
Read More